Muhammed Ahmed-Reda Elosman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammed Ahmed-Reda Elosman has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bahar Tunctan
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Türkiye
3 shared publications - Sefika Pinar Senol
Department of Pharmacy Services, Health Services Vocational School, Tarsus University, Tarsus, Türkiye
3 shared publications - Tuba Kara
Department of Pathology, Faculty of Medicine, Mersin University, Mersin, Türkiye
3 shared publications - Elif Ikiz
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Türkiye
2 shared publications Elif İkIz
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Türkiye
1 shared publication- Lutfiye Kara
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Türkiye
1 shared publication
Latest Publications
- 30 September 2026
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 26, 1-16
Inhibition of NOX2 Prevents Impairment of Cardiovascular Response and Inflammatory Tissue Injury Mediated by Nitrosative/ Oxidative Stress in the Lipopolysaccharide-Induced Septic Shock Model in Rats
Introduction: It is unknown whether inhibition of nicotinamide adenine dinucleotide phosphate oxidase (NOX) 2 has protective effects against the impaired cardiovascular response and inflammatory tissue injury mediated by nitrosative/ oxidative stress in bacterial septic shock. Therefore, using the NOX2 inhibitor NOX2ds-stat, the effects of NOX2 inhibition on cardiovascular response were explored in a rat septic shock model induced by lipopolysaccharide (LPS), in relation to cardiovascular/renal inflammatory tissue injury. Methods: Mean arterial pressure and heart rate were obtained non-invasively using a tail cuff device in rats before and at 1, 2, 3, and 4 hours after injection of saline or LPS. The rats were treated with NOX2ds-stat (0.1, 0.3, or 1 mg/kg) 1 hour following saline or LPS injection. The diazotization method was used to measure nitrite levels in the sera and cardiovascular/renal tissues. The changes in tissue expression of proteins and/or their phosphorylation status related to nuclear factor (NF)-κB/inducible nitric oxide synthase (iNOS)- and NOX2-mediated nitrosative/oxidative stress, as well as peroxisome proliferator-activated receptor (PPAR) α/β/γ, were assessed by the immunoblotting method. Using hematoxylin and eosin staining, histopathological changes in the tissues were evaluated. Results: A decrease in blood pressure by 48 mmHg and an increase in heart rate by 112 bpm were observed 4 hours after LPS injection. While the expression/ phosphorylation of gp91phox, p47phox, 3-nitrotyrosine, NF-κB p65, iNOS, Vasodilator- Stimulated Phosphoprotein (VASP), and interleukin (IL)-1β proteins was enhanced in the thoracic aorta, renal artery, heart, and kidney tissues, in addition to the levels of nitrite in the sera and tissues of LPS-injected animals, the expression/phosphorylation of endothelial nitric oxide synthase (eNOS), PPARα, PPARβ, and PPARγ was decreased. The LPS-induced changes were ameliorated by NOX2ds-stat (1 mg/kg). NOX2ds-stat also attenuated the LPS-induced increase in scores reflecting inflammatory tissue injury. Discussion: These findings indicate that selective inhibition of NOX2 prevents both impairment of cardiovascular response and cardiovascular/renal tissue injury, presumably through suppression of NF-κB/iNOS- and NOX2-mediated nitrosative/ oxidative stress associated with increased expression of anti-inflammatory PPARα/β/γ in the rat septic shock model induced by bacterial LPS. Further studies are required to determine whether NOX2 inhibition benefits patients with septic shock. Conclusion: This study provides novel insights into the pathophysiological mechanisms of septic shock and highlights the potential therapeutic value of targeting NOX2 to improve cardiovascular response and inflammatory tissue injury.
- 30 September 2026
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 26, 1-16
Inhibition of NOX2 Prevents Impairment of Cardiovascular Response and Inflammatory Tissue Injury Mediated by Nitrosative/ Oxidative Stress in the Lipopolysaccharide-Induced Septic Shock Model in Rats
Introduction: It is unknown whether inhibition of nicotinamide adenine dinucleotide phosphate oxidase (NOX) 2 has protective effects against the impaired cardiovascular response and inflammatory tissue injury mediated by nitrosative/ oxidative stress in bacterial septic shock. Therefore, using the NOX2 inhibitor NOX2ds-stat, the effects of NOX2 inhibition on cardiovascular response were explored in a rat septic shock model induced by lipopolysaccharide (LPS), in relation to cardiovascular/renal inflammatory tissue injury. Methods: Mean arterial pressure and heart rate were obtained non-invasively using a tail cuff device in rats before and at 1, 2, 3, and 4 hours after injection of saline or LPS. The rats were treated with NOX2ds-stat (0.1, 0.3, or 1 mg/kg) 1 hour following saline or LPS injection. The diazotization method was used to measure nitrite levels in the sera and cardiovascular/renal tissues. The changes in tissue expression of proteins and/or their phosphorylation status related to nuclear factor (NF)-κB/inducible nitric oxide synthase (iNOS)- and NOX2-mediated nitrosative/oxidative stress, as well as peroxisome proliferator-activated receptor (PPAR) α/β/γ, were assessed by the immunoblotting method. Using hematoxylin and eosin staining, histopathological changes in the tissues were evaluated. Results: A decrease in blood pressure by 48 mmHg and an increase in heart rate by 112 bpm were observed 4 hours after LPS injection. While the expression/ phosphorylation of gp91phox, p47phox, 3-nitrotyrosine, NF-κB p65, iNOS, Vasodilator- Stimulated Phosphoprotein (VASP), and interleukin (IL)-1β proteins was enhanced in the thoracic aorta, renal artery, heart, and kidney tissues, in addition to the levels of nitrite in the sera and tissues of LPS-injected animals, the expression/phosphorylation of endothelial nitric oxide synthase (eNOS), PPARα, PPARβ, and PPARγ was decreased. The LPS-induced changes were ameliorated by NOX2ds-stat (1 mg/kg). NOX2ds-stat also attenuated the LPS-induced increase in scores reflecting inflammatory tissue injury. Discussion: These findings indicate that selective inhibition of NOX2 prevents both impairment of cardiovascular response and cardiovascular/renal tissue injury, presumably through suppression of NF-κB/iNOS- and NOX2-mediated nitrosative/ oxidative stress associated with increased expression of anti-inflammatory PPARα/β/γ in the rat septic shock model induced by bacterial LPS. Further studies are required to determine whether NOX2 inhibition benefits patients with septic shock. Conclusion: This study provides novel insights into the pathophysiological mechanisms of septic shock and highlights the potential therapeutic value of targeting NOX2 to improve cardiovascular response and inflammatory tissue injury.
- Open Access
- 12 August 2026
- Published by Pensoft Publishers in Pharmacia
- Vol. 73, e206332
Effects of RIPK1 inhibitor necrostatin-1s on cardiovascular responses and inflammatory damage in a bilateral hind limb I/R injury model in rats
Objectives : This study investigated the effects of the receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor necrostatin-1s (Nec-1s) on cardiovascular responses and inflammatory damage in a bilateral hind limb ischemia/reperfusion (I/R) injury model in rats. Methods : The I/R injury model consisted of 3 h of ischemia followed by 24 h of reperfusion. Nec-1s was injected intraperitoneally into the rats 1 h before reperfusion. Results : Nec-1s prevented the hypotensive and tachycardic responses to I/R. The I/R-induced increases in the expression or activity of RIPK1, RIPK3, mixed lineage kinase domain-like pseudokinase, high-mobility group box 1, inhibitor of κB kinase α/β/γ, inhibitor of κBα, nuclear factor-kB p65, inducible nitric oxide synthase, cyclooxygenase-2, and interleukin-1β in cardiac, renal, pulmonary, hepatic, and cerebral tissues, as well as in the serum nitrite and prostaglandin I 2 levels of the rats, were prevented by Nec-1s. Nec-1s attenuated the elevation in scores for I/R-induced histopathological changes only in the heart. Conclusion : These findings revealed that Nec-1s prevents the deterioration of cardiovascular responses and inflammatory tissue damage in a hind limb I/R model in rats.
- 12 August 2026
- Published by Pensoft Publishers in Pharmacia
- Vol. 73, e206332
Open AccessEffects of RIPK1 inhibitor necrostatin-1s on cardiovascular responses and inflammatory damage in a bilateral hind limb I/R injury model in rats
Objectives : This study investigated the effects of the receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor necrostatin-1s (Nec-1s) on cardiovascular responses and inflammatory damage in a bilateral hind limb ischemia/reperfusion (I/R) injury model in rats. Methods : The I/R injury model consisted of 3 h of ischemia followed by 24 h of reperfusion. Nec-1s was injected intraperitoneally into the rats 1 h before reperfusion. Results : Nec-1s prevented the hypotensive and tachycardic responses to I/R. The I/R-induced increases in the expression or activity of RIPK1, RIPK3, mixed lineage kinase domain-like pseudokinase, high-mobility group box 1, inhibitor of κB kinase α/β/γ, inhibitor of κBα, nuclear factor-kB p65, inducible nitric oxide synthase, cyclooxygenase-2, and interleukin-1β in cardiac, renal, pulmonary, hepatic, and cerebral tissues, as well as in the serum nitrite and prostaglandin I 2 levels of the rats, were prevented by Nec-1s. Nec-1s attenuated the elevation in scores for I/R-induced histopathological changes only in the heart. Conclusion : These findings revealed that Nec-1s prevents the deterioration of cardiovascular responses and inflammatory tissue damage in a hind limb I/R model in rats.
- Top Cited Papers
- 29 April 2025
- Published by Elsevier in Current Molecular Pharmacology
- Vol. 17, 1-14
RIPK1/RIPK3/MLKL Necrosome Contributes to the Sepsis-Induced Cardiorenal Necroptotic Inflammatory Injury and Mortality
Introduction: Due to its critical role in inflammation and necroptotic cell death, RIPK1 has been considered a prominent therapeutic drug target for managing a wide variety of diseases, including sepsis. Therefore, we aimed to investigate whether the RIPK1-driven necroptotic pathway contributes to the nitrosative stress-mediated cardiorenal inflammatory necroptotic injury and mortality using RIPK1 inhibitor, Nec-1s, in the murine sepsis model induced by LPS. Methods: Experiments were performed using mice injected intraperitoneally with DMSO or Nec-1s with saline and/or LPS. Following euthanasia and 6 hours after the injection of these agents, arteriovenous blood samples, hearts, and kidneys of the animals were collected. Serum MPO, iNOS, CKMB, creatinine, and HMGB1 levels were measured by ELISA. Associated proteins were measured by immunoblotting. H&E staining was used to evaluate histopathological changes in the tissues. In the mortality studies, the mice were monitored every 6 hours for mortality up to 96 hours after saline, LPS, DMSO, and/or Nec-1s injection. Results: In the LPS-injected mice, a rise in serum MPO, iNOS, CK-MB, creatinine, and HMGB1 levels was associated with the enhanced expression/activity of RIPK1/RIPK3/MLKL necrosome, HMGB1, iNOS, nitrotyrosine, gp91phox, and p47phox, in addition to scores related to histopathological changes in their tissues. Nec-1s attenuated the LPS-induced changes. Mortality rates of 10%, 50%, and 60% were observed at the 24th, 36th, and 48th hours, respectively, in the LPS-treated mice. When endotoxemic mice were treated with Nec-1s, mortality rates were 60%, 90%, and 100% at 18, 30, and 42 hours, respectively. Conclusion: These findings suggest that RIPK1/RIPK3/MLKL necrosome contributes to not only LPS-induced nitrosative stress-mediated cardiorenal inflammatory necroptotic injury, but also mortality.
- 29 April 2025
- Published by Elsevier in Current Molecular Pharmacology
- Vol. 17, 1-14
Top Cited PapersRIPK1/RIPK3/MLKL Necrosome Contributes to the Sepsis-Induced Cardiorenal Necroptotic Inflammatory Injury and Mortality
Introduction: Due to its critical role in inflammation and necroptotic cell death, RIPK1 has been considered a prominent therapeutic drug target for managing a wide variety of diseases, including sepsis. Therefore, we aimed to investigate whether the RIPK1-driven necroptotic pathway contributes to the nitrosative stress-mediated cardiorenal inflammatory necroptotic injury and mortality using RIPK1 inhibitor, Nec-1s, in the murine sepsis model induced by LPS. Methods: Experiments were performed using mice injected intraperitoneally with DMSO or Nec-1s with saline and/or LPS. Following euthanasia and 6 hours after the injection of these agents, arteriovenous blood samples, hearts, and kidneys of the animals were collected. Serum MPO, iNOS, CKMB, creatinine, and HMGB1 levels were measured by ELISA. Associated proteins were measured by immunoblotting. H&E staining was used to evaluate histopathological changes in the tissues. In the mortality studies, the mice were monitored every 6 hours for mortality up to 96 hours after saline, LPS, DMSO, and/or Nec-1s injection. Results: In the LPS-injected mice, a rise in serum MPO, iNOS, CK-MB, creatinine, and HMGB1 levels was associated with the enhanced expression/activity of RIPK1/RIPK3/MLKL necrosome, HMGB1, iNOS, nitrotyrosine, gp91phox, and p47phox, in addition to scores related to histopathological changes in their tissues. Nec-1s attenuated the LPS-induced changes. Mortality rates of 10%, 50%, and 60% were observed at the 24th, 36th, and 48th hours, respectively, in the LPS-treated mice. When endotoxemic mice were treated with Nec-1s, mortality rates were 60%, 90%, and 100% at 18, 30, and 42 hours, respectively. Conclusion: These findings suggest that RIPK1/RIPK3/MLKL necrosome contributes to not only LPS-induced nitrosative stress-mediated cardiorenal inflammatory necroptotic injury, but also mortality.